Skip to main content
. 2019 Jul 2;11(7):601. doi: 10.3390/v11070601

Table 2.

Clinical laboratory data dynamics.

Day-Post Admission 0 2 4 7 9 11 12 14 15
Normal Values
AP (mm/Hg) 90/50 100/60 120/80 115/70 110/70 114/70 100/75 90/60
Blood test
Leukocyte
(109 cell/L)
3.5–11.0 14.74 18.48 13.6 16.67 8.9 7.3 4.9 4.5
Hemoglobin (g/L) 130–170 140 137 95 103 101 82 78 91
Erythrocyte
(1012 cell/L)
4.2–6.9 4.91 4.87 3.2 3.42 3.49 2.95 2.79 3.2
Hematocrit 39–62 39.6 38.4 27 29.13 31 25.7 24.3 28.3
Thrombocyte
(109 cells/L)
140–450 5 3 39 65 21 49 38 53
Arterial Blood Gas test
pH 7.45 7.07 7.47 7.44 7.43 7.4 7.2
P CO2 (mmHg) 33–45 24.5 28.9 35.4 40.6 32.3 52.1
P O2 (mmHg) 75–100 45.5 46.6 41.8 41.2 65.4
HCO3- (mEq/L) 21–28 13.3 20,6 23.6 29.1 24.8
BE -8.8 -2.6 -1 1,6 -2.4
02 SAT (%) 94–100 74.7 81 89
Biochemical analysis
K+ (mM/L) 3.5–5.0 4.9 4.0 4.3 4.3 6.6 5.4 5.1 7.3
Na+ (mM/L) 135–145 141 143 146 141 140 144 142 141
Cl- (mM/L) 95–105 92 95 99 96 90 95
Bilirubin (μM/L) 2–25 20 47.1 49 54.9
Bilirubin, direct (μM/L) 0–9 9 7
PTI (%) 72–123 55 69 60 78
PTI by Quick (%) 78–142 49.8 61 66.3
Fibrinogen B (mg/dL) 1.7–4.2 1.9 2.5 1.8 3.3 6
Spontaneous fibrinolysis (%) 10–20 ˃50 ˃40 ˃45 ˃40 ˃40 ˃40 ˃40
Soluble fibrinomonomeric complexes (SFMC) (U) 0.36–0.48 5.5 4.5 6.5 4
Activated partial thromboplastin time (aPTT) (s) 30–40 51 29 38.2 43 40 39.8
Antithrombin (AT) lll (%) 76–126 86.6% 56%
International normalised ratio (INR) 0.82–1.18 1.7 1.54 1.69 1.2 1.2 1.2 1.46 1.37
D dimer (ng/μL) + + ++ + + +
Procalcitonin (ng/mL) 0–0.15 12.8 12.8 ˃12.8
C-reactive protein (CRP) (mg/L) 0–6 48 96
Amylase (U/L) 25–190 140 600 852
Alanine aminotransferase (ALT) (U/L) 5–56 510 1211 1250 389 98 21
Aspartate transaminase (AST) (U/L) 8–40 738 2316 2400 500 136 40
Lactate dehydrogenase (LDH) (U/L) 140–280 3328
Creatinine (μM/L) 60–118 286 547 949
Urea (mM/L) 3–7 14 19.9 43 29 50 65 56
Urinalysis
Protein (g/L) absent 0.15 0.9 4 4 1.54
Red Blood Cells (RBC) (cells/field) 0–3 10–20 4–5 many many many